Rising Covid Cases, Talk Of Second Booster Drive Moderna Stock Higher. Will The Rally Continue?

Forbes

Covid-19 vaccine maker Moderna stock has rallied by close to 29% over the last week (five trading days), compared to the S&P 500 which was up by about 6% over the same period. The stock also remains up by about 18% over the past month. There are multiple factors driving the stock higher…